ORIS:NASDAQOriental Rise Holdings Limited Analysis
Data as of 2026-04-22 - not real-time
$0.43
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Technical outlook: ORIS trades at $0.43, well below its 20‑day SMA of 0.64, 50‑day SMA of 0.80 and 200‑day SMA of 2.51, signaling a deep bearish bias. The 14‑day RSI sits at 32, indicating oversold conditions but not a clear reversal, while the MACD line is marginally under the signal line (-0.075 vs -0.074), reinforcing the bearish momentum. Volume is on a decreasing trend and the 30‑day volatility is extreme at 185%, suggesting price swings could be sharp.
Fundamental outlook: The company reports a 35% revenue decline, razor‑thin profit margin (0.04%) and negative operating and free cash flow, highlighting cash‑burn concerns. Despite a minuscule price‑to‑book ratio of 0.0066 and a market cap of roughly $2.2 M, the max drawdown of -98%, high beta (~1.2), and lack of dividend make the stock highly speculative. Investors should weigh the deep discount against the severe earnings weakness and liquidity constraints before deciding.
Fundamental outlook: The company reports a 35% revenue decline, razor‑thin profit margin (0.04%) and negative operating and free cash flow, highlighting cash‑burn concerns. Despite a minuscule price‑to‑book ratio of 0.0066 and a market cap of roughly $2.2 M, the max drawdown of -98%, high beta (~1.2), and lack of dividend make the stock highly speculative. Investors should weigh the deep discount against the severe earnings weakness and liquidity constraints before deciding.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- Price well below all major moving averages
- Bearish MACD and decreasing volume
- Extreme short‑term volatility
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- Continued revenue contraction and negative cash flow
- High beta and thin trading liquidity
- Elevated regulatory and geographic risks in China
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Exceptionally low price‑to‑book ratio suggesting potential value floor
- Possibility of restructuring or acquisition
- Persistent earnings weakness and cash‑burn remain concerns
Key Metrics & Analysis
Financial Health
Revenue Growth-35.00%
Profit Margin0.04%
ROE0.01%
ROA0.08%
Debt/Equity0.47
P/B Ratio0.0
Op. Cash Flow$-309000
Free Cash Flow$-675875
Technical Analysis
TrendBearish
RSI32.2
Support$0.42
Resistance$1.14
MA 20$0.64
MA 50$0.80
MA 200$2.51
MACDBearish
VolumeDecreasing
Fear & Greed Index87.13
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta1.21
Volatility185.59%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.